SPYGLASSPHARMA, INC.
Profile
Company Names
SPYGLASSPHARMA, INC.
SPYGLASS OPHTHALMICS, INC.
Addresses
27061 ALISO CREEK ROAD, SUITE 100, ALISO VIEJO, CA 92656
27081 ALISO CREEK ROAD, SUITE 125, ALISO VIEJO, CA 92656
26431 CROWN VALLEY PARKWAY, SUITE 250, MISSION VIEJO, CA 92691
Phone Numbers
949-284-6904
949-275-0912
Entity Type:
CORPORATION
Industry:
OTHER HEALTH CARE
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$134,792,329.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-05-30
$74,999,989.00
$74,999,989.00
$0.00
Equity
3
2023-07-06
$40,009,993.00
$90,019,986.00
$50,009,993.00
Equity
2
2020-12-29
$13,749,996.00
$37,499,996.00
$23,750,000.00
Equity
1
2019-05-22
$6,032,351.00
$6,032,351.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALI
BEHBAHANI
DIRECTOR
ROTATION MEDICAL INC
| DENALI MEDICAL II, INC.
| MINERVA SURGICAL INC
| PROSPEX MEDICAL III, INC.
| OCULEVE, INC.
| CVRX INC
| IVANTIS, INC.
| ADAPTIMMUNE LTD
| CARDIONOMIC, INC.
| CVRX, INC.
| SOLACE THERAPEUTICS INC
| CRISPR THERAPEUTICS AG
| OYSTER POINT PHARMA, INC.
| GENOCEA BIOSCIENCES, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| SPYGLASS OPHTHALMICS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| NEA BH SPV, L.P.
| NEA BH SPV II, L.P.
| MONTE ROSA THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| NEW ENTERPRISE ASSOCIATES 18, L.P.
| NEA 18 VENTURE GROWTH EQUITY, L.P.
| FIRSTLIGHT BIO, INC.
| NEXO THERAPEUTICS, INC.
| LAUNCHPAD THERAPEUTICS, INC.
| NEA SH SPV, L.P.
| SPYGLASSPHARMA, INC.
| NEA RP SPV, L.P.
| NEA CH SPV, L.P.
| NEA TS 2024 SPV, L.P.
| NEA SECONDARY OPPORTUNITY FUND, L.P.
| TUNE THERAPEUTICS, INC.
TAK
CHEUNG
DIRECTOR
MALIK
KAHOOK
EXECUTIVE OFFICER, DIRECTOR
BILAL
KHAN
DIRECTOR
PATRICK
MOONEY
EXECUTIVE OFFICER, DIRECTOR
KIRK
NIELSEN
DIRECTOR
INCEPTUS NEWCO1 INC.
| ZYGA TECHNOLOGY, INC.
| INNOVATIVE PULMONARY SOLUTIONS, INC.
| MEDICAL DEVICE INNOVATIONS, INC.
| HOLAIRA, INC.
| RESPICARDIA, INC.
| INARI MEDICAL, INC.
| VERSANT VENTURE CAPITAL V, L.P.
| VERSANT AFFILIATES FUND V, L.P.
| VERSANT OPHTHALMIC AFFILIATES I, L.P.
| VERSANT VENTURE CAPITAL V (CANADA), LP
| NEUWAVE MEDICAL, INC.
| CETERIX ORTHOPAEDICS, INC.
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| METAVENTION, INC.
| NUVAIRA, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| MONTERIS MEDICAL US, INC.
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| ALLEVIANT MEDICAL, INC.
| CVRX, INC.
| SPYGLASS OPHTHALMICS, INC.
| MOXE HEALTH CORP
| ARTELON, INC.
| IVEACARE, INC.
| RAMPART IC, INC.
| VI1, INC.
| OKAMI MEDICAL, INC.
GEOFF
PARDO
DIRECTOR
FACET SOLUTIONS INC
| TEARSCIENCE, INC.
| INOVA LABS, INC.
| IWALK, INC.
| VAPOTHERM INC
| BIONX MEDICAL TECHNOLOGIES, INC.
| CVRX, INC.
| AXONICS MODULATION TECHNOLOGIES, INC.
| ABLATIVE SOLUTIONS, INC.
| EARGO, INC.
| SPIRE, INC.
| SHOULDER INNOVATIONS, INC.
| GT MEDICAL TECHNOLOGIES, INC.
| NALU MEDICAL, INC.
| ALLEVIANT MEDICAL, INC.
| SPYGLASSPHARMA, INC.
ZACH
SCHEINER
DIRECTOR
GLENN
SUSSMAN
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

